Neuroacanthocytosis

This is a rare genetic condition that affects the brain and nerves. It causes problems like movement issues, seizures, and difficulty walking. It's caused by changes in a gene that affects how proteins move inside nerve cells. This leads to the characteristic 'thorny' red blood cells seen in the blood.

Condition

What people with Neuroacanthocytosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Botox (Botulinum Toxin Type A) for Neuroacanthocytosis?

NameHow it went

About Neuroacanthocytosis

What It Is

Neuroacanthocytosis is the name for a small group of rare inherited brain disorders that gradually damage the basal ganglia, the deep brain regions that help control movement, behavior and motivation. The result is a combination of involuntary movements, changes in mood and behavior, and problems with thinking. The name comes from a blood clue: many people with these conditions have red blood cells with a spiky, thorny outline, called acanthocytes. Today the term mainly covers two genetic diseases. The more common one, and the one usually meant by neuroacanthocytosis, is chorea-acanthocytosis, now often called VPS13A disease. It typically begins in early to mid-adulthood, around age 30 on average. Its movement problems include chorea (brief, irregular jerking movements), dystonia (involuntary muscle tightening that causes twisting or abnormal postures) and tics. The mouth, tongue and throat are often affected early: people may bite their tongue, lips or cheeks without meaning to, make grunts or other sounds, or find their tongue pushes food out while they try to eat. Speech and swallowing can become difficult. Nearly half of people with VPS13A disease have seizures, and weakness from nerve and muscle involvement is common. The second, McLeod syndrome (XK disease), is rarer, affects mainly men and tends to start later. Its brain symptoms are similar, but it also often affects the heart muscle and carries an unusual blood type that matters for transfusions. Because behavior changes such as obsessive-compulsive symptoms, impulsivity or loss of self-care can come first, and because the movements can look like Huntington's disease, these conditions are often misdiagnosed for years.

Causes & Risk Factors

Neuroacanthocytosis is caused by changes (variants) in a single gene, not by anything a person did. Nothing in daily life starts the disease, although sleep loss and alcohol can make seizures more likely in people who have them. VPS13A disease is caused by variants in the VPS13A gene and is inherited in an autosomal recessive pattern. That means a person is affected only when they inherit a nonworking copy of the gene from each parent. The parents are usually healthy carriers. When both parents carry a variant, each of their children has a 25% chance of being affected, a 50% chance of being an unaffected carrier, and a 25% chance of inheriting neither variant. The VPS13A protein helps move fats between compartments inside cells; why its loss mainly damages the brain and red blood cells is still being worked out. McLeod syndrome is caused by variants in the XK gene on the X chromosome. Men, who have one X chromosome, are affected; women who carry the variant usually have no brain symptoms, though a few develop milder problems later in life. A son of a carrier mother has a 50% chance of being affected. The conditions are extremely rare. VPS13A disease is estimated to affect roughly 1 in a million people, and it is probably underrecognized.

How It's Diagnosed

Diagnosis usually starts with a neurologist, often a movement disorder specialist, who notices a telling pattern: chorea or dystonia centered on the mouth and tongue, lip or tongue biting, seizures, weakness or reduced reflexes, and behavior changes. Family history matters, especially affected brothers or sisters. Several tests support the suspicion. A blood smear can show acanthocytes, but these cells are not always present and can appear late, so a normal smear does not rule the condition out. Creatine kinase (CK), an enzyme released from damaged muscle, is often raised, and liver enzymes may be high too, sometimes leading to a search for liver disease before the true cause is found. Brain MRI often shows shrinkage of the caudate nucleus, part of the basal ganglia. Nerve and muscle tests can show the nerve and muscle involvement. Genetic testing confirms the diagnosis: two disease-causing VPS13A variants for VPS13A disease, or an XK variant for McLeod syndrome. Because the movements resemble Huntington's disease, testing for Huntington's is often part of the workup. In McLeod syndrome, blood typing that shows the McLeod blood group pattern is another clue. Once the family's variants are known, relatives can be offered carrier testing, and couples can consider prenatal or preimplantation testing.

Treatment Options

There is no cure for neuroacanthocytosis and no treatment that slows it, so care focuses on easing symptoms, keeping people as independent as possible and preventing complications. It works best with a team: neurology, psychiatry, physical and occupational therapy, speech and swallowing therapy, nutrition and genetics. Involuntary movements are treated much as they are in Huntington's disease. Tetrabenazine (Xenazine) lowers dopamine signaling and is used for chorea; it is approved for Huntington's chorea and used off-label here. Because it can worsen depression and has been linked to suicidal thoughts, mood is watched closely, which matters in a condition where psychiatric symptoms are common. Antipsychotic medicines are another option for chorea and can also help with agitation or psychosis. Botulinum toxin injections can relax specific muscles, such as those that cause tongue or jaw dystonia. A small number of people have had deep brain stimulation, a surgically implanted device that sends electrical pulses to movement circuits, with at least short-term benefit; it is a specialist decision for selected cases. Seizures are treated with standard anti-seizure medicines such as levetiracetam or valproate. In VPS13A disease, carbamazepine and lamotrigine are best avoided because they may worsen involuntary movements, and avoiding sleep deprivation and alcohol helps reduce seizure risk. Depression, obsessive-compulsive symptoms and other behavioral changes are treated with the usual psychiatric approaches, and a psychiatrist is often a key member of the team. Practical support makes a large difference. Speech therapy and communication devices help when speech becomes hard to understand. Swallowing therapy, food texture changes and, when needed, a feeding tube placed through the abdomen (gastrostomy) can stop weight loss and lower the risk of food going into the lungs. Physical and occupational therapy and mobility aids help with falls and daily tasks. McLeod syndrome adds two specific precautions. Regular heart checks, such as heart rhythm monitoring and echocardiograms, are recommended even without symptoms, and some people need a pacemaker or implanted defibrillator. Because of their rare blood type, men with McLeod syndrome can react to ordinary donor blood, so compatible blood must be arranged, and banking one's own blood ahead of time is encouraged. Research into treatments that target the disease process is ongoing, but none has yet shown clinical benefit; a small trial of the cancer drug dasatinib did not improve symptoms.

What to Expect

Neuroacanthocytosis gets worse over time, usually over many years to decades, but the pace and the mix of symptoms vary widely, even between siblings with the same gene change. Movement problems tend to increase with age, and in later stages stiffness and slowness similar to Parkinson's disease can replace some of the jerking movements. For some people the condition leads to major disability within a few years, while others progress more slowly. Daily life is shaped by speech, eating and behavior as much as by movement. Meals can become slow and tiring, and keeping weight up is a recurring goal. Speech may become hard to understand, so finding other ways to communicate early helps. Behavioral and psychiatric changes are often the hardest part for families and have a large effect on work, relationships and independence. Many people eventually need help with daily care. Life expectancy is shortened. In VPS13A disease, published reports describe deaths between the late 20s and early 60s, and sudden deaths, sometimes linked to seizures, have been reported. In McLeod syndrome, heart complications are a major concern, which is why regular heart monitoring matters. Because the conditions are so rare, care is often coordinated through a specialist center, with regular follow-up to adjust medicines, check swallowing, weight, seizures and mood, and plan ahead. Genetic counseling helps relatives understand their own risk, and patient organizations for neuroacanthocytosis can connect families with others and with research.

When to Seek Help

See a neurologist if involuntary movements of the face, mouth or tongue, unexplained tongue or lip biting, or a mix of movement and behavior changes develop, especially if a relative has a similar illness or Huntington's testing has come back negative. Contact the care team promptly about a first seizure or seizures that are becoming more frequent, choking or coughing during meals, steady weight loss, or a noticeable change in mood, including new or worsening depression or thoughts of self-harm. For someone with McLeod syndrome, new palpitations, fainting, shortness of breath or swelling of the legs should be checked quickly, since they can signal heart involvement. A seizure lasting longer than five minutes, or repeated seizures without the person waking up in between, is a medical emergency: call 911.

Questions to Ask Your Doctor

  1. 1.Which form of neuroacanthocytosis is this, and should my brothers, sisters or children be offered genetic testing?
  2. 2.Which of my symptoms are most likely to improve with treatment, and what are the trade-offs of the medicines you suggest?
  3. 3.How will we keep track of swallowing, weight and seizures, and when would a feeding tube make sense?
  4. 4.Do I need heart monitoring or special arrangements for blood transfusions?
  5. 5.Is there a specialist center, research study or patient organization you would recommend?

Last reviewed • Oct 2026

Educational content, not medical advice.